Margaret has 20+ years of experience in global drug development during which she has held a range of technical, line, project, and programme management roles. Margaret played a key role in the team that delivered AstraZeneca’s first novel anticancer agent IRESSA which is now licensed around the world for the treatment of lung cancer and has led many large scale change programmes. Margaret currently heads the Research and Development Project Management Centre of Excellence, a group tasked with creating and driving project management excellence across Research and Development in AstraZeneca. Margaret leads a global team with team members based in the UK, Sweden, and the US.